https://www.selleckchem.com/pr....oducts/atuzabrutinib
Recent technical advances have made new minimally invasive techniques possible to treat large volume (80 ml) benign prostatic hyperplasia (BPH). The endoscopic transperitoneal adenomectomy of the prostate (ETAP) is a new minimally invasive technique developed in our centre. The aim of this study was to describe the safety, efficacy and to evaluate our learning curve in ETAP. This was a single-centre study that enrolled eighty-eight consecutive patients with large BPH who underwent ETAP. Pre-, per- and postoperative data were p
Like
Comment
Share
